TOVALT Trademark

Trademark Overview


On Tuesday, December 3, 2024, a trademark application was filed for TOVALT with the United States Patent and Trademark Office. The USPTO has given the TOVALT trademark a serial number of 98882592. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 3, 2024. This trademark is owned by Newcastle Bioscience, LLC. The TOVALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's dise...

General Information


Serial Number98882592
Word MarkTOVALT
Filing DateTuesday, December 3, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's disease, Huntington's disease and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia and depression; pain relief medications and analgesics.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNewcastle Bioscience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNaples, FL 34108

Trademark Events


Event DateEvent Description
Tuesday, December 3, 2024NEW APPLICATION ENTERED
Tuesday, December 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED